January 30, 2019

Government recognises ‘very significant work’ by industry on Brexit planning

The Government has recognised the industry for “very significant work” in planning for Brexit. At the Oireachtas Committee on Health on Wednesday, the Secretary General of […]
January 29, 2019

European lawmakers on course to weaken IP incentives environment

Lawmakers in Brussels are on track towards weakening the environment for the discovery and adoption of medical innovation, potentially putting at risk the development of new […]
January 18, 2019

Brexit demands us all to work together for patients

There’s a saying in Brussels called going ‘into the tunnel’. It’s when negotiators get together to try to plot a path to resolving Brexit. As the […]
December 27, 2018

Two-Thirds of People Say Patients’ Wait For New Medicines is ‘Unacceptable’ – Ipsos MRBI

Two-thirds of people feel it is ‘unacceptable’ that life-changing medicines are available to patients in other countries before our own can get them, according to a […]
December 13, 2018

The pharma year unwrapped

As we near the end of the year, it’s a good time to look back on just some of the highlights of our public communications and […]
December 6, 2018

IPHA uses roundtable to outline industry’s Brexit preparations

With the Brexit clock ticking down, IPHA  has hosted a roundtable to outline the steps the industry is taking to to minimise any potential disruption to […]
November 21, 2018

Vice Chancellor of Oueen’s University Belfast outlines new vision for life sciences

Professor Ian Greer, the new Vice Chancellor of Queen’s University Belfast gave an inspirational Annual Lecture of the Association of the British Pharmaceutical Industry at Stormont […]
November 12, 2018

Two-Thirds of People Say Patients’ Wait For New Medicines is ‘Unacceptable’ – Ipsos MRBI Survey for

Two-thirds of people feel it is ‘unacceptable’ that life-changing medicines are available to patients in other countries before our own can get them, according to a […]
November 9, 2018

Patients Waiting Over Twice as Long for New Medicines Compared to Rest of Western Europe, Says IPHA

Patients in Ireland are waiting more than twice as long as patients in other western European countries for access to many vital new medicines, figures from […]